<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2023-29-6-593-602</article-id><article-id custom-type="edn" pub-id-type="custom">BSTDUA</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-2353</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Влияние новой коронавирусной инфекции на параметры сосудистой жесткости у пациентов с артериальной гипертензией</article-title><trans-title-group xml:lang="en"><trans-title>Influence of a new coronavirus infection on the arterial stiffness in patients with hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4266-5900</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Авдеева</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Avdeeva</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Авдеева Ирина Владимировна — кандидат медицинских наук, доцент кафедры «Терапия»</p><p>Пенза</p></bio><bio xml:lang="en"><p>Irina V. Avdeeva, MD, PhD, Associate Professor, Therapy Department</p><p>Penza</p></bio><email xlink:type="simple">eliseeva.iv1@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9409-3484</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павленко</surname><given-names>К. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlenko</surname><given-names>K. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Павленко Ксения Игоревна — аспирант 2‑го года обучения кафедры «Терапия», ассистент кафедры «Терапия»</p><p>Пенза</p></bio><bio xml:lang="en"><p>Ksenia I. Pavlenko, MD, 2nd year Post-GraduateStudent, Therapy Department, Assistant, Therapy Department</p><p>Penza</p></bio><email xlink:type="simple">Ksenia-p2017@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7130-0316</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Салямова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Salyamova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Салямова Людмила Ивановна — кандидат медицинских наук, доцент кафедры «Терапия»</p><p>Пенза</p></bio><bio xml:lang="en"><p>Lyudmila I. Salyamova, MD, PhD, Associate Professor, Therapy Department</p><p>Penza</p></bio><email xlink:type="simple">l.salyamova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2080-2639</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукьянова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukyanova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лукьянова Марина Владимировна — кандидат медицинских наук, доцент кафедры «Терапия»</p><p>Пенза</p></bio><bio xml:lang="en"><p>Marina V. Lukyanova, MD, PhD, Associate Professor, Therapy Department</p><p>Penza</p></bio><email xlink:type="simple">mavlu2002@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7463-9259</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Олейников</surname><given-names>В. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Oleinikov</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олейников Валентин Эливич — доктор медицинских наук, профессор, заведующий кафедрой «Терапия»</p><p>Тел.: 8 (8412) 64–31–74</p><p>ул. Красная, д. 40, г. Пенза, Россия, 440026</p></bio><bio xml:lang="en"><p>Valentin E. Oleinikov, MD, PhD, DSc, Professor, Head, Therapy Department</p><p>40 Krasnaya str., Penza, 440026 Russia</p></bio><email xlink:type="simple">v.oleynikof@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное образовательное учреждение высшего образования «Пензенский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Penza State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>07</day><month>10</month><year>2023</year></pub-date><volume>29</volume><issue>6</issue><fpage>593</fpage><lpage>602</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Авдеева И.В., Павленко К.И., Салямова Л.И., Лукьянова М.В., Олейников В.Э., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Авдеева И.В., Павленко К.И., Салямова Л.И., Лукьянова М.В., Олейников В.Э.</copyright-holder><copyright-holder xml:lang="en">Avdeeva I.V., Pavlenko K.I., Salyamova L.I., Lukyanova M.V., Oleinikov V.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/2353">https://htn.almazovcentre.ru/jour/article/view/2353</self-uri><abstract><p>Цель исследования — сравнительный анализ параметров липидного профиля, сосудистой жесткости и эндотелиальной функции у пациентов с артериальной гипертензией (АГ), обследованных до пандемии COronaVIrus Disease-2019 (COVID-19), и пациентов с АГ, перенесших COVID-19.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Включено 133 человека: 72 пациента с АГ, наблюдавшихся в 2010–2015 годах, 61 больной АГ, перенесший COVID-19. Проводили биохимический анализ крови с определением уровня глюкозы, общего холестерина, триглицеридов, холестерина липопротеинов высокой плотности. Рассчитывали уровень холестерина липопротеинов низкой плотности и холестерина невысокой плотности. Оценивали параметры сосудистой жесткости с помощью объемной сфигмографии, функцию эндотелия определяли на основании значений, полученных в пробе с постокклюзионной реактивной гиперемией.</p></sec><sec><title>Результаты</title><p>Результаты. По результатам биохимического анализа крови отмечен более высокий уровень общего холестерина и холестерина невысокой плотности у пациентов с АГ, перенесших COVID-19. В сравниваемых группах зарегистрированы сопоставимые показатели эндотелиальной функции в пробе с постокклюзионной реактивной гиперемией. При этом по данным объемной сфигмографии наибольшие значения показателей сосудистой жесткости (скорость распространения пульсовой волны в аорте, артериях преимущественно эластического типа, сердечно-лодыжечный сосудистый индекс справа и слева) выявлены у пациентов с АГ, перенесших COVID-19. Проведен однофакторный регрессионный анализ, с помощью которого подтверждено негативное влияние перенесенного COVID-19 на параметры артериальной ригидности.</p></sec><sec><title>Заключение</title><p>Заключение. Больные АГ в постковидном периоде представляют особо уязвимую когорту населения по риску развития и прогрессирования кардиоваскулярной патологии, включая сосудистые катастрофы.</p><p>Включение объемной сфигмографии в перечень обследования, вероятно, позволит на ранних стадиях выявить повышение артериальной жесткости с последующей медикаментозной коррекцией.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. The aim of the study was to compare the parameters of lipid profile, arterial stiffness and endothelial function in patients with arterial hypertension (HTN), examined before the COronaVIrus Disease-2019 (COVID-19) pandemic, and patients with HTN who underwent COVID-19.</p></sec><sec><title>Design and methods</title><p>Design and methods. In total, 133 people were included: 72 patients with HTN examined in 2010–2015, 61 patients with HTN who survived after COVID-19. A biochemical blood test was performed to determine the level of glucose, total cholesterol, triglycerides, and high-density lipoprotein cholesterol. The level of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol was calculated. The parameters of arterial stiffness were assessed using volume sphygmography, endothelial function was determined based on the values obtained in the sample with post-occlusive reactive hyperemia.</p></sec><sec><title>Results</title><p>Results. According to the results of a biochemical blood test, a significantly higher level of total cholesterol and non-high-density lipoprotein cholesterol was noted in patients with HTN who underwent COVID-19. In the compared groups, comparable indicators of endothelial function were registered with post-occlusive reactive hyperemia. At the same time, according to volume sphygmography, the highest values of arterial stiffness indicators (pulse wave velocity in the aorta, pulse wave velocity in elastic arteries, cardio-ankle vascular index on the right and left) were found in patients with HTN who had undergone COVID-19. A univariate regression analysis was carried out, which confirmed a significant negative effect of the transferred COVID-19 on the parameters of arterial stiffness.</p></sec><sec><title>Conclusions</title><p>Conclusions. Patients with HTN in the post-COVID period represent a particularly vulnerable cohort of the population in terms of the risk of developing and progressing cardiovascular pathology, including vascular events. The inclusion of volume sphygmography in the list of examinations will probably allow early detection of an increase in arterial stiffness with subsequent drug correction.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>артериальная гипертензия</kwd><kwd>объемная сфигмография</kwd><kwd>сосудистая жесткость</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>hypertension</kwd><kwd>volumetric sphygmography</kwd><kwd>vascular stiffness</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено за счет гранта Российского научного фонда, проект № 23–25–00381</funding-statement><funding-statement xml:lang="en">The study is supported by a grant of the Russian Science Foundation project №23–25–00381</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кобалава Ж. Д., Конради А. О., Недогода С. В., Шляхто Е. В., Арутюнов Г. П., Баранова Е. И. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):3786. doi:10.15829/1560-4071-2020-3-3786 [Kobalava ZD, Konradi AO, Nedogoda SV, Shlyakhto EV, Arutyunov GP, Baranova EI et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. doi:10.15829/1560-4071-2020-3-3786. In Russian].</mixed-citation><mixed-citation xml:lang="en">Kobalava ZD, Konradi AO, Nedogoda SV, Shlyakhto EV, Arutyunov GP, Baranova EI et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. doi:10.15829/1560-4071-2020-3-3786. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. doi:10.1016/S0140-6736(21)01330-1</mixed-citation><mixed-citation xml:lang="en">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. doi:10.1016/S0140-6736(21)01330-1</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Конради А. О., Недогода С. В., Недошивин А. О., Ратова Л. Г., Либис Р. А., Арутюнов Г. П. и др. Современная антигипертензивная терапия: возможности уникальной российской фиксированной комбинации рамиприла и индапамида. Российский кардиологический журнал. 2020;25(3):3782. doi:10.15829/1560-4071-2020-3-3782 [Konradi AO, Nedogoda SV, Nedoshivin AO, Ratova LG, Libis RA, Arutyunov GP et al. Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide. Russian Journal of Cardiology. 2020;25(3):3782. doi:10.15829/1560-4071-2020-3-3782. In Russian].</mixed-citation><mixed-citation xml:lang="en">Konradi AO, Nedogoda SV, Nedoshivin AO, Ratova LG, Libis RA, Arutyunov GP et al. Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide. Russian Journal of Cardiology. 2020;25(3):3782. doi:10.15829/1560-4071-2020-3-3782. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Бойцов С. А., Погосова Н. В., Аншелес А. А., Бадтиева В. А., Балахонова Т. В., Барбараш О. Л. и др. Кардиоваскулярная профилактика 2022. Российские национальные рекомендации. Российский кардиологический журнал. 2023;28(5):5452. doi:10.15829/1560-4071-2023-5452 [Boytsov SA, Pogosova NV, Ansheles AA, Badtieva VA, Balakhonova TV, Barbarash OL et al. Cardiovascular prevention 2022. Russian national guidelines. Russian Journal of Cardiology. 2023;28(5):5452. doi:10.15829/1560-4071-2023-5452. In Russian].</mixed-citation><mixed-citation xml:lang="en">Boytsov SA, Pogosova NV, Ansheles AA, Badtieva VA, Balakhonova TV, Barbarash OL et al. Cardiovascular prevention 2022. Russian national guidelines. Russian Journal of Cardiology. 2023;28(5):5452. doi:10.15829/1560-4071-2023-5452. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ротарь О. П., Колесова Е. П., Могучая Е. В., Бояринова М. А., Хромова Н. В., Алиева А. С. и др. Генетические маркеры метаболического синдрома в российской популяции (по материалам исследования ЭССЕ-РФ). Артериальная гипертензия. 2019;25(5):467–477. doi:10.18705/1607-419X-2019-25-5-467-477 [Rotar OP, Kolesova EP, Moguchaya EV, Boyarinova MA, Khromova NV, Alieva АS et al. Genetic markers of the metabolic syndrome in the Russian population (based on the ESSE-RF study). Arterial’naya Gipertenziya = Arterial Hypertension. 2019;25(5):467–477. doi:10.18705/1607-419X-2019-25-5-467-477. In Russian].</mixed-citation><mixed-citation xml:lang="en">Rotar OP, Kolesova EP, Moguchaya EV, Boyarinova MA, Khromova NV, Alieva АS et al. Genetic markers of the metabolic syndrome in the Russian population (based on the ESSE-RF study). Arterial’naya Gipertenziya = Arterial Hypertension. 2019;25(5):467–477. doi:10.18705/1607-419X-2019-25-5-467-477. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Муромцева Г. А., Концевая А. В., Константинов В. В., Артамонова Г. В., Гатагонова Т. М., Дупляков Д. В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования ЭССЕ-РФ. Кардиоваскулярная терапия и профилактика. 2014;13(6):4–11. doi:10.15829/1728-8800-2014-6-4-11 [Muromtseva GA, Kontsevaya AV, Konstantinov VV, Artamonova GV, Gatagonova TM, Duplyakov DV et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012-2013 years. The results of ECVD-RF. Cardiovascular Therapy and Prevention. 2014;13(6):4–11. doi:10.15829/1728-8800-2014-6-4-11. In Russian].</mixed-citation><mixed-citation xml:lang="en">Muromtseva GA, Kontsevaya AV, Konstantinov VV, Artamonova GV, Gatagonova TM, Duplyakov DV et al. The prevalence of non-infectious diseases risk factors in Russian population in 2012– 2013 years. The results of ECVD-RF. Cardiovascular Therapy and Prevention. 2014;13(6):4–11. doi:10.15829/1728-8800-2014-6-4-11. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Anand S, Abonyi S, Arbour L, Balasubramanian K, Brok J, Castleden H et al. Explaining the variability in cardiovascular risk factors among first nations communities in Canada: a population-based study. Lancet Planet Heal. 2019;3(12):e511-e520. doi:10.1016/S2542-5196(19)30237-2</mixed-citation><mixed-citation xml:lang="en">Anand S, Abonyi S, Arbour L, Balasubramanian K, Brok J, Castleden H et al. Explaining the variability in cardiovascular risk factors among first nations communities in Canada: a population-based study. Lancet Planet Heal. 2019;3(12):e511‑e520. doi:10.1016/S2542-5196(19)30237-2</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Арутюнов Г. П., Тарловская Е. И., Арутюнов А. Г., Беленков Ю. Н., Конради А. О., Лопатин Ю. М. и др. Клинические особенности постковидного периода. Результаты международного регистра «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (АКТИВ SARSCoV-2)». Предварительные данные (6 месяцев наблюдения). Российский кардиологический журнал. 2021;26(10):4708. doi:10.15829/1560-4071-2021-4708 [Arutyunov GP, Tarlovskaya EI, Arutyunov AG, Belenkov YuN, Konradi AO, Lopatin YuM et al. Clinical features of the bridge period. Results of the international registry “Analysis of the dynamics of comorbid diseases in patients who have been infected with SARS-CoV-2 (ACTIVE SARSCoV-2)”. Preliminary data (6 months of follow-up). Russian Journal of Cardiology. 2021;26(10):4708. doi:10.15829/1560-4071-2021-4708. In Russian].</mixed-citation><mixed-citation xml:lang="en">Arutyunov GP, Tarlovskaya EI, Arutyunov AG, Belenkov YuN, Konradi AO, Lopatin YuM et al. Clinical features of the bridge period. Results of the international registry “Analysis of the dynamics of comorbid diseases in patients who have been infected with SARS-CoV‑2 (ACTIVE SARSCoV‑2)”. Preliminary data (6 months of follow-up). Russian Journal of Cardiology. 2021;26(10):4708. doi:10.15829/1560-4071-2021-4708. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Бубнова М. Г., Аронов Д. М. COVID-19 и сердечно-сосудистые заболевания: от эпидемиологии до реабилитации. Пульмонология. 2020;30(5):688–699. doi:10.18093/0869-0189-2020-30-5-688-699 [Bubnova MG, Aronov DM. COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation. Pulmonologiya = Pulmonology. 2020;30(5):688–699. doi:10.18093/0869-0189-2020-30-5-688-699. In Russian].</mixed-citation><mixed-citation xml:lang="en">Bubnova MG, Aronov DM. COVID‑19 and cardiovascular diseases: from epidemiology to rehabilitation. Pulmonologiya = Pulmonology. 2020;30(5):688–699. doi:10. 18093/0869-0189-2020-30-5-688-699. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gameil M, Marzouk R, Elsebaie A, Rozaik S. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021;11(1):74. doi:10.1186/s43066-021-00144-1</mixed-citation><mixed-citation xml:lang="en">Gameil M, Marzouk R, Elsebaie A, Rozaik S. Long-term clinical and biochemical residue after COVID‑19 recovery. Egypt Liver J. 2021;11(1):74. doi:10.1186/s43066-021-00144-1</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel A et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;5(2);395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5</mixed-citation><mixed-citation xml:lang="en">Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel A et al. Endothelial cell infection and endotheliitis in COVID‑19. Lancet. 2020;5(2);395(10234):1417–1418. doi:10.1016/S0140-6736(20)30937-5</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Arrebola-Moreno AL, Laclaustra M, Kaski JC. Noninvasive assessment of endothelial function in clinical practice. Rev Esp Cardiol. 2012;65(1):80–90. doi:10.1016/j.recesp.2011.09.012</mixed-citation><mixed-citation xml:lang="en">Arrebola-Moreno AL, Laclaustra M, Kaski JC. Noninvasive assessment of endothelial function in clinical practice. Rev Esp Cardiol. 2012;65(1):80–90. doi:10.1016/j.recesp.2011.09.012</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Беленков Ю. Н., Привалова Е. В., Каплунова В. Ю., Зекцер В. Ю., Виноградова Н. Н., Ильгисонис И. С. и др. Метаболический синдром: история развития, основные критерии диагностики. Рациональная Фармакотерапия в Кардиологии. 2018;14(5):757–764. doi:10.20996/1819-6446-2018-14-5-757-764 [Belenkov YuN, Privalova EV, Kaplunova VY, Zektser VY, Vinogradova NN, Ilgisonis IS et al. Metabolic syndrome: development of the issue, main diagnostic criteria. Rational Pharmacotherapy in Cardiology. 2018;14(5):757–764. doi:10.20996/1819-6446-2018-14-5-757-764. In Russian].</mixed-citation><mixed-citation xml:lang="en">Belenkov YuN, Privalova EV, Kaplunova VY, Zektser VY, Vinogradova NN, Ilgisonis IS et al. Metabolic syndrome: development of the issue, main diagnostic criteria. Rational Pharmacotherapy in Cardiology. 2018;14(5):757–764. doi:10.20996/1819-6446-2018-14-5-757-764. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ghoneim S, Butt M, Hamid O, Shah A, Asaad I. The incidence of COVID-19 in patients with metabolic syndrome and nonalcoholic steatohepatitis: a population-based study. Metabol Open. 2020;8:100057. doi:10.1016/j.metop.2020.100057</mixed-citation><mixed-citation xml:lang="en">Ghoneim S, Butt M, Hamid O, Shah A, Asaad I. The incidence of COVID‑19 in patients with metabolic syndrome and nonalcoholic steatohepatitis: a population-based study. Metabol Open. 2020;8:100057. doi:10.1016/j.metop.2020.100057</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Кашталап В.В. Медикаментозная терапия артериальной гипертонии и дислипидемии: возможности препарата Липертанс (на примере клинического наблюдения). Российский кардиологический журнал. 2022;27(11):5285. doi:10.15829/1560-4071-2022-5285 [Kashtalap VV. Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation). Russian Journal of Cardiology. 2022;27(11):5285. doi:10.15829/1560-4071-2022-5285. In Russian].</mixed-citation><mixed-citation xml:lang="en">Kashtalap VV. Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation). Russian Journal of Cardiology. 2022;27(11):5285. doi:10.15829/1560-4071-2022-5285. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Панченкова Л. А., Андреева Л. А., Хамидова Х. А., Юркова Т. Е., Мартынов А. И. Артериальная гипертония, ассоциированная с метаболическим синдромом: фокус на суточные профили центрального аортального давления и сосудистой жесткости. Евразийский кардиологический журнал. 2016;(3):6–12. doi:10.38109/2225-1685-2016-3-6-12 [Panchenkova LA, Andreeva LA, Khamidova KA, Yurkova TE, Martynov AI. Arterial hypertension associated with metabolic syndrome: focus on daily profiles of central aortic pressure and vascular stiffness. Eurasian Heart Journal. 2016;(3):6–12. doi:10.38109/2225-1685-2016-3-6-12. In Russian].</mixed-citation><mixed-citation xml:lang="en">Panchenkova LA, Andreeva LA, Khamidova KA, Yurkova TE, Martynov AI. Arterial hypertension associated with metabolic syndrome: focus on daily profiles of central aortic pressure and vascular stiffness. Eurasian Heart Journal. 2016;(3):6–12. doi:10.38109/2225-1685-2016-3-6-12. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: is covid-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9(5):1417. doi:10.3390/jcm9051417</mixed-citation><mixed-citation xml:lang="en">Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: is covid‑19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9(5):1417. doi:10.3390/jcm9051417</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Синякин И. А., Андриевская И. А., Ишутина Н. А., Смирнова Н. А. COVID-19-ассоциированная дислипидемия: роль липидов и жирных кислот в патогенезе SARS-CoV-2 инфекции. Бюллетень физиологии и патологии дыхания. 2022;(83):107–118. doi:10.36604/1998-5029-2022-83-107-118 [Sinyakin IА, Аndrievskaya IА, Ishutina NА, Smirnova NА. COVID-19-associated dyslipidemia: the role of lipid and fatty acids in the pathogenesis of SARS-CoV-2 infection. Bulletin Physiology and Pathology of Respiration. 2022;(83):107-118. doi:10.36604/1998-5029-2022-83-107-118. In Russian].</mixed-citation><mixed-citation xml:lang="en">Sinyakin IА, Аndrievskaya IА, Ishutina NА, Smirnova NА. COVID‑19‑associated dyslipidemia: the role of lipid and fatty acids in the pathogenesis of SARS-CoV‑2 infection. Bulletin Physiology and Pathology of Respiration. 2022;(83):107–118. doi:10.36604/1998-5029-2022-83-107-118. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zuin M, Rigatelli G, Bilato C, Cervellati C, Zuliani G, Roncon L. Prognostic role of metabolic syndrome in COVID-19 patients: a systematic review meta-analysis. Viruses. 2021;13(10):1938. doi:10.3390/v13101938</mixed-citation><mixed-citation xml:lang="en">Zuin M, Rigatelli G, Bilato C, Cervellati C, Zuliani G, Roncon L. Prognostic role of metabolic syndrome in COVID‑19 patients: a systematic review me-ta-analysis. Viruses. 2021;13(10):1938. doi:10.3390/ v13101938</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sorokin A, Karathanasis S, Yang Z, Freeman L, Kotani K, Remaley A. COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 2020;34(8):9843–9853. doi:10.1096/fj.202001451</mixed-citation><mixed-citation xml:lang="en">Sorokin A, Karathanasis S, Yang Z, Freeman L, Kotani K, Remaley A. COVID‑19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 2020;34(8):9843–9853. doi:10.1096/fj.202001451</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">ACCORD Study Group; Ginsberg H, Elam M, Lovato L, Crouse J, Leiter L, Linz P et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1563–1574. doi:10.1056/NEJMoa1001282</mixed-citation><mixed-citation xml:lang="en">ACCORD Study Group; Ginsberg H, Elam M, Lovato L, Crouse J, Leiter L, Linz P et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1563–1574. doi:10.1056/NEJMoa1001282</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Корякина Л. Б., Пивоваров Ю. И., Курильская Т. Е., Сергеева А. С., Бабушкина И. В. Дисфункция сосудистого эндотелия при артериальной гипертонии и ишемической болезни сердца (обзор литературы). Acta Biomedica Scientifica. 2013;(2(1)):165–170 [Koryakina LB, Pivovarov YuI, Kurilskaya TE, Sergeyeva AS, Babushkina IV. Dysfunction of vascular endothelium at arterial hypertension and coronary disease (literature review). Acta Biomedica Scientifica. 2013;2(1):165–170. In Russian].</mixed-citation><mixed-citation xml:lang="en">Koryakina LB, Pivovarov YuI, Kurilskaya TE, Sergeyeva AS, Babushkina IV. Dysfunction of vascular endothelium at arterial hypertension and coronary disease (literature review). Acta Biomedica Scientifica. 2013;2(1):165–170. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Гумерова В. Е., Сайганов С. А., Гомонова В. В. Параметры артериальной жесткости у пациентов с артериальной гипертензией при наличии и отсутствии субклинического каротидного атеросклероза. Артериальная гипертензия. 2021;27(4):427–435. doi:10.18705/1607-419X-2021-27-4-427-435 [Gumerova VE, Sayganov SA, Gomonova VV. Parameters of arterial stiffness in hypertensive patients with and without subclinical carotid atherosclerosis. Arterial’naya Gipertenziya = Arterial Hypertension. 2021;27(4):427–435. doi:10.18705/1607-419X-2021-27-4-427-435. In Russian].</mixed-citation><mixed-citation xml:lang="en">Gumerova VE, Sayganov SA, Gomonova VV. Parameters of arterial stiffness in hypertensive patients with and without subclinical carotid atherosclerosis. Arterial’naya Gipertenziya = Arterial Hypertension. 2021;27(4):427–435. doi:10.18705/1607-419X-2021-27-4-427-435. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Tesauro M, Mauriello A, Rovella V, Annicchiarico-Petruzzelli M, Cardillo C, Melino G et al. Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 281(5):471–482. doi:10.1111/joim.12605</mixed-citation><mixed-citation xml:lang="en">Tesauro M, Mauriello A, Rovella V, Annicchiarico-Petruzzelli M, Cardillo C, Melino G et al. Arterial ageing: from endothelial dysfunction to vascular calcification. J Intern Med. 281(5):471–482. doi:10.1111/joim.12605</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Булгакова С.В., Гусякова О.А., Тренева Е.В., Захарова Н.О., Николаева А.В. Влияние липидного обмена на темп старения пациентов с артериальной гипертонией. Клиническая лабораторная диагностика. 2018;63(8):495–499. doi:10.18821/0869-2084-2018-63-8-495-499 [Bulgakova SV, Gusyakova OA, Treneva EV, Zakharova NO, Nikolaeva AV. The effect of lipid metabolism on the aging rate of patients with arterial hypertension. Clinical Laboratory Diagnostics. 2018;63(8):495–499. doi:10.18821/0869-2084-2018-63-8-495-499. In Russian].</mixed-citation><mixed-citation xml:lang="en">Bulgakova SV, Gusyakova OA, Treneva EV, Zakharova NO, Nikolaeva AV. The effect of lipid metabolism on the aging rate of patients with arterial hypertension. Clinical Laboratory Diagnostics. 2018;63(8): 495–499. doi:10.18821/0869-2084-2018-63-8-495-499. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Laurent S, Marais L, Boutouyrie P. The noninvasive assessment of vascular aging. Can J Cardiol. 2016;32(5):669-679. doi:10.1016/j.cjca.2016.01.039</mixed-citation><mixed-citation xml:lang="en">Laurent S, Marais L, Boutouyrie P. The noninvasive assessment of vascular aging. Can J Cardiol. 2016;32(5):669–679. doi:10.1016/j.cjca.2016.01.039</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kar M. Vascular dysfunction and its cardiovascular consequences during and after COVID-19 infection: a narrative review. Vasc Health Risk Manag. 2022;18:105–112. doi:10.2147/VHRM.S355410</mixed-citation><mixed-citation xml:lang="en">Kar M. Vascular dysfunction and its cardiovascular consequences during and after COVID‑19 infection: a narrative review. Vasc Health Risk Manag. 2022;18:105–112. doi:10.2147/VHRM.S355410</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Bruno R, Spronck B, Hametner B, Hughes A, Lacolley P, Mayer C et al. Covid-19 effects on ARTErial StIffness and vascular AgeiNg: CARTESIAN Study Rationale and Protocol. Artery Res. 2020;27(2):59. doi:10.2991/artres.k.201124.001</mixed-citation><mixed-citation xml:lang="en">Bruno R, Spronck B, Hametner B, Hughes A, Lacolley P, Mayer C et al. Covid‑19 effects on ARTErial StIffness and vascular AgeiNg: CARTESIAN Study Rationale and Protocol. Artery Res. 2020;27(2):59. doi:10.2991/artres.k.201124.001</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Васюк Ю. А., Иванова С. В., Школьник Е. Л., Котовская Ю. В., Милягин В. А., Олейников В. Э. и др. Согласованное мнение российских экспертов по оценке артериальной жесткости в клинической практике. Кардиоваскулярная терапия и профилактика. 2016;15(2):4–19. doi:10.15829/1728-8800-2016-2-4-19 [Vasyuk YA, Ivanova SV, Shkolnik EL, Kotovskaya YV, Milyagin VA, Oleynikov VE et al. Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice. Cardiovascular Therapy and Prevention. 2016;15(2):4–19. doi:10.15829/1728-8800-2016-2-4-19. In Russian].</mixed-citation><mixed-citation xml:lang="en">Vasyuk YA, Ivanova SV, Shkolnik EL, Kotovskaya YV, Milyagin VA, Oleynikov VE et al. Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice. Cardiovascular Therapy and Prevention. 2016;15(2):4–19. doi:10.15829/1728-8800-2016-2-4-19. In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Franklin S. Arterial stiffness and hypertension: a two way street? Hypertension. 2005;45(3):349–351. doi:10.1161/01.HYP.0000157819.31611.87</mixed-citation><mixed-citation xml:lang="en">Franklin S. Arterial stiffness and hypertension: a two way street? Hypertension. 2005;45(3):349–351. doi:10.1161/01.HYP.0000157819.31611.87</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Endes S, Caviezel S, Schaffner E, Dratva J, Schindler C, Künzli N et al. Associations of novel and traditional vascular biomarkers of arterial stiffness: results of the SAPALDIA 3 cohort study. PLoS One. 2016;11(9):e0163844. doi:10.1371/journal.pone.0163844</mixed-citation><mixed-citation xml:lang="en">Endes S, Caviezel S, Schaffner E, Dratva J, Schindler C, Künzli N et al. Associations of novel and traditional vascular biomarkers of arterial stiffness: results of the SAPALDIA 3 cohort study. PLoS One. 2016;11(9):e0163844. doi:10.1371/journal.pone.0163844</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Aydın E, Kant A, Yilmaz G. Evaluation of the cardio-ankle vascular index in COVID-19 patients. Rev Assoc Med Bras (1992). 2022;68(1):73–76. doi:10.1590/1806-9282.20210781</mixed-citation><mixed-citation xml:lang="en">Aydın E, Kant A, Yilmaz G. Evaluation of the cardio-ankle vascular index in COVID‑19 patients. Rev Assoc Med Bras (1992). 2022;68(1):73–76. doi:10.1590/1806-9282.20210781</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
